The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Lyka Labs Ltd

Lyka Labs Ltd

BSE 500259 · NSE LYKALABS · ISIN INE933A01014 · Group T · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹73.01

-1.87%

BSE close, 28 August 2026

Market cap

₹263.95 cr

3.6 cr shares · Micro cap

Free float

₹110.43 cr

as published

P/E · P/B

-8.5× · 2.02×

EPS ₹-8.58 · BV ₹36.14

FY25-26 rev / PAT

120.91 / -32.29

₹ cr, as filed

Filings, window

11

2 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹44.49 52-WK HIGH ₹104.80 ₹73.01 47% of range
Against 52-week high-30.3%
Against 52-week low+64.1%
Day change-1.87%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-8.58
Price / earnings-8.51×
Price / book2.02×
Book value — derived, price ÷ P/B₹36.14
Return on equity-23.72%
Operating margin11.85%
Net margin4.96%

Consistency check

P/B ÷ P/E, which must equal ROE
-23.74%
ROE as published
-23.72%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 42.31 2.10 0.58 11.85% 4.96%
Mar-26 · Q 28.03 -29.77 -8.50 -96.28% -106.21%
FY25-26 120.91 -32.29 -9.18 -17.74% -26.71%

Quarter on quarter

Revenue, quarter on quarter
+50.9%
Net profit, quarter on quarter
+107.1%
Operating margin, quarter on quarter
+10,813 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM2
General2
Newspaper Publication2
Board Meeting1
Compliance Certificate1
Trading Window1
Procedural sub-total9
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 2 selected · busiest 2026-08-10

Filing rhythm · the twelve most recent

2026-07-202026-10-08

SelectedProcedural

Filings

11 in the window · 16 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    As per the letter attached

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    As per the letter attached

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    As per the letter attached

    Company Update / Newspaper Publication View filing →

  4. 11 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    As per the letter attached

    AGM/EGM / AGM View filing →

  5. 11 August 2026 ·

    General

    Revised Press Release On Unaudited Financial Results For The Q1 June, 2026

    As per the letter attached

    Company Update / General View filing →

  6. 10 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    As per the letter attached

    AGM/EGM / AGM View filing →

  7. 10 August 2026 ·

    General

    Press Release For Unaudited Financial Results Of Q1 June 2026

    As per the letter atatched

    Company Update / General View filing →

  8. 10 August 2026 ·

    Results

    Financial Results For June 2026

    As per the letter attached

    Result / Financial Results View filing →

  9. 10 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Dated 10Th August, 2026

    As per the letter attached

    Board Meeting / Outcome of Board Meeting View filing →

  10. 24 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Board Meeting To Be Held On Monday, 10Th August, 2026

    Lyka Labs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve As per the letter attached

    Board Meeting / Board Meeting View filing →

  11. 20 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    As per the letter attached

    Company Update / Newspaper Publication View filing →

RSS feed for Lyka Labs Ltd · the 50 most recent filings